Do general practitioners know patients' preferences? An empirical study on the agency relationship at an aggregate level using a discrete choice experiment

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Line Bjørnskov PedersenDorte Gyrd-Hansen

Abstract

This study investigated whether general practitioners (GPs) know patients' preferences regarding a number of organizational characteristics in general practice (i.e., waiting time on the telephone, opening hours, waiting time to the appointment, distance to the general practice, waiting time in the waiting room, consultation time, and whether the GP or assisting personnel performs routine tasks) to examine whether there is a basis for improving the agency relationship at an aggregate level. A total of 698 respondents from the Danish population and 969 GPs answered the questionnaire in May and September 2010. In a discrete choice experiment, GPs and patients made both forced and unforced choices, allowing us to explore the congruence of preferences 1) when patients must choose a new GP and 2) when they can stay with their current GP. Results show that in the forced choice, preferences are seen to differ. In the unforced choice also, preferences differ--mainly because GPs overestimate their own importance to the patients. Rank orders, however, are similar for both GPs and patients. It is concluded that GPs do not have a precise knowledge of patients' preferences. However, in the unforced choice, GPs do know on which attributes to...Continue Reading

References

Jul 29, 1998·Social Science & Medicine·L Rochaix
Sep 5, 1994·Journal of Health Economics·R LabelleT Rice
Apr 17, 2002·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Michel WensingRichard Grol
Jul 12, 2002·Family Practice·Peter VedstedFrede Olesen
Apr 7, 2004·Health Economics·Mandy Ryan, Diane Skåtun
May 9, 2006·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Benedicte Carlsen, Arild Aakvik
Apr 17, 2007·Social Science & Medicine·Sherman Folland
Jun 17, 2008·Journal of Health Services Research & Policy·Karen GerardHelen Baxter
Jul 16, 2008·PharmacoEconomics·Emily Lancsar, Jordan Louviere
Aug 1, 2002·Expert Review of Pharmacoeconomics & Outcomes Research·Rosalie VineyJordan Louviere

❮ Previous
Next ❯

Citations

Jun 21, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Line Bjørnskov Pedersen, Dorte Gyrd-Hansen
Jul 10, 2014·PharmacoEconomics·Michael D ClarkEsther W de Bekker-Grob
Nov 19, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Chiara SeghieriSabina Nuti
Feb 6, 2016·Scandinavian Journal of Primary Health Care·Line Bjørnskov Pedersen, Jørgen Nexøe
Mar 3, 2015·The Patient·Esther W de Bekker-GrobElly A Stolk
Aug 27, 2016·BMC Family Practice·Pieter van den HomberghJozé Braspenning
Oct 17, 2017·The Patient·Caroline M VassKatherine Payne
Dec 6, 2019·Journal of Family Medicine and Primary Care·Alfredo ManuliRocco Salvatore Calabrò
Jul 13, 2017·BMC Health Services Research·Kim-Sarah KleijChristian Krauth
Jun 5, 2021·International Journal of Health Economics and Management·Seema KackerDavid Bishai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.